Bixiye
bc-com-pharmprogpolicynotifctn-final-2.8.23-eff-4.1.23.pdf
Natiijooyinka Raadinta
Soo bandhiga 1531 - 1540 ee natiijooyinka 3688
Bixiye
P9-23 Medical Policy Updates: Coupe Health and Self-Funded Benefit Plans managed by Blue Cross and Blue Shield of Alabama
Taariikhda uu dhaqangalayo Barnaamijka: 01, Feb 2023
Bixiye
P10-23 Update: Modifier -53 Reimbursement Changes, Effective April 3, 2023
Taariikhda uu dhaqangalayo Barnaamijka: 01, Feb 2023
Bixiye
2023 February Bulletins
Taariikhda uu dhaqangalayo Barnaamijka: 01, Feb 2023
Bixiye
QP8-23 Commercial Formulary Addition for Growth Hormone Therapeutic Class: Genotropin® (somatropin)
Taariikhda uu dhaqangalayo Barnaamijka: 08, Feb 2023
Bixiye
QP9-23 Commercial Pharmacy Benefit Exclusion for Select Medications
Taariikhda uu dhaqangalayo Barnaamijka: 08, Feb 2023
Bixiye
P77R1-22 Update: New Medical, Medical Drug and Behavioral Health Policy Management Updates: Effective January 30, 2023
Taariikhda uu dhaqangalayo Barnaamijka: 01, Feb 2023
Bixiye
P6-23 eviCore Healthcare Specialty Utilization Management (UM) Program: Sleep Management Clinical Guideline Updates
Taariikhda uu dhaqangalayo Barnaamijka: 01, Feb 2023
Bixiye
P7-23 Updated Minnesota Health Care Programs (MHCP) and Minnesota Senior Health Options (MSHO) Prior Authorization and Medical Policy Requirements
Taariikhda uu dhaqangalayo Barnaamijka: 01, Feb 2023